Ilika Technologies delivers first shipments of stacked batteries

Ilika, a pioneer in solid state battery technology, have made a number of first customer shipments of stacked Stereax M300 batteries from its UK manufacturing facility. Further to the announcement of 11 April 2023, these shipments are the first of a series of planned deliveries of Stereax M300 batteries to customers including CubeWorks, the developer of millimeter-scale smart sensing solutions for IoT, and Lura Health, a leading developer of wearable intraoral biosensors for salivary diagnostics. Stereax batteries can be configured such that they can be stacked, which provides customers with the flexibility to adapt the battery capacity for their application.

The small form factor of M300 batteries is of particular interest to Ilika’s customers due to their compact, high-density and high-power characteristics. CubeWorks is designing CubiSens, a next generation sensing platform, aiming to transform biopharma cold chain logistics, security control, asset protection and environment monitoring.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Ilika plc

More articles like this

Ilika plc

Ilika’s journey from 2015-2019

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Ilika plc

Ilika celebrates 20 years of innovation and growth

Ilika Technologies has reached its 20th anniversary. Originally focused on high-throughput materials discovery, the company was founded by CEO Graeme Purdy to commercialise technology from the University of Southampton’s Department of Chemistry. The early years, led

Ilika plc

Ilika provides comprehensive update on FY24 trading

Ilika’s unaudited trading results for the year ended 30 April 2024 have aligned with management expectations. The Company anticipates reporting revenues of approximately £2.1 million (2023: £0.7 million), with an EBITDA loss excluding share-based payments of